Antoni Manzano

Dr. Antoni Manzano

Anesthesiology, Critical Care and Pain Medecine, Hospital Clínic de Barcelona, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MGMarc Gimenez-Mila
Marc Gimenez-Mila
AMAntoni Manzano
Antoni Manzano
OAOmar Abdul-Jawad Altisent
Omar Abdul-Jawad Altisent
MAMaria José Arguis
Maria José Arguis
SBSalvatore Brugaletta
Salvatore Brugaletta
MTManel Sabaté Tenas
Manel Sabaté Tenas
Background: Data on high flow nasal oxygenation (HFNO) efficacy in hypoxia prevention in transcatheter aortic valve replacement (TAVR) are conflictive. We aimed to determine the benefit of HFNO in preventing the occurrence of desaturations during TAVR. Methods: An investigator-initiated, proof of concept, single-centre, randomised, and controlled trial on 132 adult patients who were scheduled to undergo transfemoral TAVR was conducted. Patients were randomised (1:1) to HFNO (H-group) with a flow rate of 50 L min−1 and FiO2 0.6 or standard of care oxygen therapy (S-group). The primary endpoint was the number of patients with a desaturation episode (SpO2 < 93%) for >10 s during TAVR. Secondary outcomes included arterial partial pressure of oxygen (pO2) 45 min from sedation start and changes in glomerular filtration rate from baseline to 12 h post-procedure. Results: Between 23 November and 24 July, a per-protocol analysis was performed in a total of 125 patients (H-group n = 64; S- group n = 61; 49 females). The number of patients with any desaturation episode was significantly lower in the H-group [13/64 (20%, 95% CI: 12–32%)] than in the S-group [31/61 (51%, 95% CI: 39–63%), RR: 0.39 (95%CI: 0.23–0.68)]. At 45 min, mean (SD) pO2 was higher in the H-group (24(9.8) kPa vs. 16.7(7.5) kPa; p < 0.005). A significant improvement in delta median (IQR) difference on glomerular filtration rate was observed in the H-group [1.6(−1–7.9) mL min−1 1.73 m−2] with respect to the S-group [0.2(−6.1–3.1) mL min−1 1.73 m−2; p-value: 0.013]. Conclusions: This trial demonstrated that HFNO provides a better oxygenation pattern than standard oxygen therapy during TAVR. Larger studies focusing on long-term clinical outcomes are warranted to evaluate the benefit of HFNO during sedation for TAVR procedures.

17 June 2024 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
AMAntoni Manzano
Antoni Manzano
GMGraciela Martinez-Pallí
Graciela Martinez-Pallí
MGMarc Gimenez-Mila
Marc Gimenez-Mila

10 October 2023 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
MAMaria De Los Ang Martinez Alberici
Maria De Los Ang Martinez Alberici
MCMaría José Carretero Casado
María José Carretero Casado
PJPurificación Matute Jimenez
Purificación Matute Jimenez
ICIrene Rovira Canudas
Irene Rovira Canudas
SCSara Vazquez Calvo
Sara Vazquez Calvo
FGFrancisco Javier Vega Guedes
Francisco Javier Vega Guedes